A carregar...
High Circulating Tie-2 is Associated with Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer
Vascular endothelial growth factor (VEGF) is a central mediator of angiogenesis in breast cancer. Research in antiangiogenic cancer treatment has been marked by the development of the monoclonal antibody bevacizumab, which targets VEGF in many solid tumors. Since patients do not equally benefit from...
Na minha lista:
| Publicado no: | Am J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4490123/ https://ncbi.nlm.nih.gov/pubmed/24577164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000046 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|